67 results on '"Warner, Timothy A."'
Search Results
2. Platelet inhibition by P2Y 12 antagonists is potentiated by adenosine signalling activators
3. Proteome and functional decline as platelets age in the circulation
4. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis
5. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis.
6. A novel genetic variant inPTGS1affects N‐glycosylation of cyclooxygenase‐1 causing a dominant‐negative effect on platelet function and bleeding diathesis
7. Profiling the eicosanoid networks that underlie the anti‐ and pro‐thrombotic effects of aspirin
8. Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
9. Molecular basis for and chemogenetic modulation of comorbidities in GABRG 2 ‐deficient epilepsies
10. Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
11. Functional Analyses of Reticulated Platelets
12. Aspirin inhibits the production of proangiogenic 15( S )‐HETE by platelet cyclooxygenase‐1
13. P2Y12receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation
14. A geospatial approach to measuring regional and sub-regional inclusive wealth: the case of resource rich West Virginia, USA
15. Inherited human group IVA cytosolic phospholipase A2deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation
16. Aspirin‐triggered 15‐epi‐lipoxin A4predicts cyclooxygenase‐2 in the lungs of LPS‐treated mice but not in the circulation: implications for a clinical test
17. Cox2 reporter gene expression and prostacylin mass spectrometry confirm vascular COX‐1 dominance for prostacyclin production
18. Kernel-Based Texture in Remote Sensing Image Classification
19. Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy
20. COX‐1, and not COX‐2 activity, regulates airway function: relevance to aspirin‐sensitive asthma
21. Stronger inhibition by nonsteroid anti‐inflammatory drugs of cyclooxygenase‐1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events
22. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2
23. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβ
24. Activation of peroxisome proliferator‐activated receptor‐γ by troglitazone (TGZ) inhibits human lung cell growth
25. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
26. PPARγ ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator‐activated receptor‐γ antagonist
27. Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors
28. Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line
29. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
30. A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2in vitroandin vivoin a substrate-sensitive manner
31. Ex vivoassay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs
32. RELATIONSHIPS BETWEEN THE ENDOTHELIN AND NITRIC OXIDE PATHWAYS
33. Synergy between cyclo‐oxygenase‐2 induction and arachidonic acid supplyin vivo: consequences for nonsteroidal antiinflammatory drug efficacy
34. Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenasein vivo: investigations using the selective inhibitors, 1400W and celecoxib
35. “I'll give it five”: The Assessment of Popular Music Performance
36. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture
37. Endothelin-1 and the periaqueductal gray area of the rat: an autoradiographic and functional pharmacological study
38. Involvement of endothelin in the pressor response following injection of NMDA to the periaqueductal gray area of rats
39. The contribution of tumour necrosis factor-α and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin
40. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists
41. Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea‐pig
42. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses
43. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids
44. Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme
45. Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670
46. Rapid degradation of endothelin-1 by an enzyme released by the rat isolated perfused mesentery
47. Characterization of endothelin (ET) receptors in the isolated gall bladder of the guinea-pig: evidence for an additional ET receptor subtype
48. Endothelin Receptor Antagonists
49. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065
50. Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.